Article
ASCO Releases A Payment Reform Model
ASCO says that it's Patient-Centered Oncology Payment model meets the criteria for an Alternative Payment Model as defined by Congress in the Medicare Access and CHIP Reauthorization Act of 2015, which replaced the Sustainable Growth Rate formula.
The American Society of Clinical Oncology (ASCO) has released the Patient-Centered Oncology Payment (PCOP) model, which expands on ASCO's payment reform proposal from last year. The organization claims that PCOP qualifies as an Alternative Payment Model as defined by the Medicare Access and CHIP Reauthorization Act of 2015 that was released by Congress last month to replace Medicare's widely criticized Sustainable Growth Rate formula.
According to ASCO PCOP will address the following:
- Education and support to help patients make the best choices about their cancer treatment,
- Rapid response for patients experiencing problems during treatment to help avoid emergency department visits or hospitalizations,
- Care coordination with other healthcare providers, and
- Continued support to patients after active treatment ends
Read the complete news release by ASCO: http://bit.ly/1Gs2ygI
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
